Navigation Links
New insights into the fate of anti-parasitics in manure and manured soils
Date:12/5/2007

In recent years, there has been growing interest in the question, if the entry of veterinary medicinal products (VMP) into soils via manure application is of environmental relevance. In a recent study, published in the November issue of the journal CLEAN, Kreuzig and co-workers now focused on the so far less investigated benzimidazole antiparasitics, adding valuable data to the so far available data set on fate and behavior of veterinary medicinal products in manure and manured soils.

An innovative experimental design for laboratory tests on VMP has been developed in order to simulate the real entry route of VMP into soil environments already under laboratory conditions. Degradation tests of VMP as 14C-labeled radiotracers in manures were conducted. On this basis, test manures containing 7-day aged VMP residues were prepared and then applied in laboratory batch tests to study degradation and sorption of VMP in manured soils. In further tests, the differentiation of microbial, chemical and photoinduced degradation were taken into account. Finally, test-plot experiments were performed under field conditions to monitor the transferability of the laboratory data to field conditions.

The benzimidazole antiparasitics flubendazole and fenbendazole mainly remained extractable in pig manure and soil samples. Antibiotics like sulfonamides, in contrast, rapidly formed non-extractable residues. Flubendazole was found unchanged while fenbendazole was accompanied by corresponding metabolites. Due to their slow degradation in pig manure, the manure storage is not considered to reduce substantially the environmental exposure. As shown by the sorption tests, both benzimidazoles did not fulfill the criteria of potential leachers. Finally, the degradation tests showed the dependence of the metabolic fate on the microbial activity in soil and on the test-manure application. These aspects, therefore, emphasized that the consideration of manure effects already under laboratory conditions supports a better understanding of the environmental fate of VMP under field conditions.


'/>"/>

Contact: Vera Koester
vkoester@wiley-vch.de
0049-620-160-6519
Wiley-Blackwell
Source:Eurekalert

Related biology technology :

1. Dental Implant Market Insights Webinar
2. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
3. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)...  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing ... that Linda Marbán, Ph.D, president and chief executive officer, is ... Cowen and Company 37th Annual Health Care Conference ... Boston, MA 29th Annual ROTH ... pm ET) Dana Point, CA ...
(Date:2/23/2017)... DIEGO and SAN FRANCISCO ... a privately-held regenerative medicine company, and Beyond Type 1, ... with type 1 diabetes, today announced a grant from ... a functional cure for type 1 and other insulin-requiring ... ViaCyte has been developing innovative stem cell-derived cell replacement ...
(Date:2/22/2017)...  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company ... products for companion animals, will host a live conference call ... discuss financial results from the fourth quarter and full year ... investors may access the audio webcast or use ... ...
(Date:2/22/2017)... ... February 22, 2017 , ... Park Systems , a leader in Atomic ... all SPIE attendees and Park customers on Feb. 27, 2017 from 12-2pm ... Jose Convention Center. The luncheon will feature a talk on Automated AFM for ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):